Blog

Category: COVID-19

Improving COVID-19 Detection using Saliva Samples instead of NPS

March 2021

  Saliva-based tests can simplify, accelerate, and increase the availability of COVID-19 testing – and potentially lead to better patient outcomes.   The COVID-19 pandemic continues to cause illness across the world, but there is hope on the horizon as improved testing, treatments, and vaccines make their way to the global population. With the emergence of new SARS-CoV-2 variants and mutations, however, it is more important than ever that testing …

The Role of B Cells and T Cells in COVID-19 Immune Response & T Cell Immunity in COVID-19 Patients

January 2021

Recent developments in COVID-19 immunology research look at the role T cells and B cells play in immune response to infection with SARS-CoV-2. The global scientific community has made great strides in characterizing the immune response to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for coronavirus disease 2019 (COVID-19). There are several studies that have been published in recent months that take a closer look at how …

Akadeum Microbubbles: The Novel Approach to COVID Research (Webinar Dec 16)

December 2020

The emergence of COVID-19 has changed life as we know it the world over. This is a fast-moving and deadly pandemic that requires novel, next-generation technology to enable ongoing research and advanced diagnostic testing. Join us on December 16 to get an inside look at how Akadeum’s products and cell separation technology are contributing to the solutions of tomorrow. In this webinar, we will cover:  An overview of the microbubble …

DATA BRIEF: Expanding COVID-19 Testing

November 2020

Early Data from Akadeum’s RNA Extraction Project for Pooled Saliva Samples   Current COVID-19 saliva testing is limited. Akadeum’s microbubbles aim to change everything. At Akadeum Life Sciences, we are actively working to develop an innovative cell separation approach that makes pooled saliva testing possible – in an accurate and cost-effective way. We have expanded our microbubble platform by functionalizing our revolutionary buoyancy-activated separation (BACS™) technology for RNA isolation in …

Back to Top